Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

BRAF Inhibitors in Melanoma Management: When Friends Become Foes

Journal of Investigative Dermatology(2021)10.1016/j.jid.2021.11.005Source: DataRank Database

BRAF Inhibitors in Melanoma Management: When Friends Become Foes is a research paper published in Journal of Investigative Dermatology (2021). On theSindex it has a DataRank of 0. It has been cited 6 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access6 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (6 grants)Impact (FWCI 0.30)OA: bronzeTopics (33)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (2)

Nihal Ahmad ORCID,Gagan Chhabra ORCID

Live enrichment

PubMed:34872726 PMC:PMC9199497 OpenAlex:https://openalex.org/W4200604644

National Institutes of Health

Grant: P30 CA014520

BLRD VA

Grant: I01 BX004221

CSRD VA

Grant: I01 CX001441

BLRD VA

Grant: IK6 BX003780

CSRD VA

Grant: I01 CX002210

U.S. Department of Veterans Affairs

FWCI

0.30

Citation Percentile

0.5%

Citation Trend

2022

2024

2025

bronzeLicense: http://www.elsevier.com/open-access/userlicense/1.0/

journalhttp://www.jidonline.org/article/S0022202X21024854/pdf

BRONZEhttp://www.jidonline.org/article/S0022202X21024854/pdf

publisherhttp://www.jidonline.org/article/S0022202X21024854/pdf

publisherhttps://api.elsevier.com/content/article/PII:S0022202X21024854?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0022202X21024854?httpAccept=text/plain

Fields of Study

Melanoma and MAPK PathwaysComputational Drug Discovery MethodsMedicineAnimalsCell Line, TumorDrug Resistance, NeoplasmFriendsHumansIndolesMelanomaMiceMutationProtein Kinase InhibitorsProto-Oncogene Proteins B-rafSulfonamidesVemurafenib

MeSH Terms

VemurafenibAnimalsHumansIndolesMelanomaMutationSulfonamidesDrug Resistance, NeoplasmFriendsCell Line, TumorProtein Kinase InhibitorsProto-Oncogene Proteins B-rafMice

Keywords

MelanomaMedicineCancer researchDermatology

Sustainable Development Goals

SDG 0: Good health and well-being